Home / Knowledge hub /
From vial to value: How GLP-1s are redefining injectable care for chronic conditions
October 3, 2025
GLP-1 growth is redefining injectable care for chronic conditions, shifting demand towards self-administered devices like prefilled syringes and autoinjectors, and elevating CDMOs to strategic partners for scaling manufacturing, ensuring compliance, and guiding device development. In this white paper, we share insights on these transformative trends.
Download your copy to discover:
- An overview of the GLP-1 market growth and its transformation of injectable therapies
- Emerging demands in manufacturing and delivery
- The strategic value of CDMOs as key partners
Get Your Copy Now
Fields marked with a * are required.
Related resources
Explore our other resources to discover valuable insights on the latest trends in drug delivery.
A bridge to the future: Our world-class Bridgeton facility
Manufacturing sterile injectables today is more complex than ever. Navigating stringent aseptic requirements, evolving regulatory expectations and the need for significant specialized investment has made the path to market increasingly challenging. A fragmented approach across development, drug substance manufacturing and fill finish remains a common industry practice that can introduce critical vulnerabilities. With every handoff, […]
Learn More
Sterile product introduction and tech transfers in a crowded market
The tech transfer landscape for sterile products is increasingly complex, with pressure to reduce time to market. Find out how to navigate common challenges and avoid costly delays or oversights in this presentation from our Director, Client Portfolio & Relationship Management, Kim Brown. Download your copy to explore: Benefits of a commercial manufacturing mindset How […]
Learn More
Aseptic injectable fill-finish facility
Through strategic investments and expansions, Kindeva Drug Delivery is on the forefront of combination product innovation. Our aseptic injectable fill-finish facility in Bridgeton, Missouri, is one example of our commitment to excellence. With the addition of this facility, we are one of only a few CDMOs capable of servicing sterile fill, device manufacture, and final […]
Learn More
Missed our PDA poster presentations? Unlock injectable & intradermal insights
Access the Presentations At the 2024 PDA Annual Meeting, experts from Kindeva Drug Delivery presented our insights on injectable and intradermal drug-device combination products. Spanning holistic design for aseptic injectable fill-finish, human factors for autoinjectors, and manufacturing of microneedle array patches (MAPs), our posters showcase our latest developments and know-how across injectable drug delivery. If […]
Learn MoreLet’s transform tomorrow together
Every patient deserves a brighter tomorrow. As your strategic partner, we are dedicated to building your lasting legacy and helping you fast-track healthier tomorrows. You dream it, we deliver it.